Kazumi Fushimi Selected Research

Kazumi Fushimi Research Topics

11	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 11/2012
9	Neoplasms (Cancer) 01/2022 - 11/2012
2	Cholangiocarcinoma 06/2021 - 11/2018
1	Neoplasm Metastasis (Metastasis) 02/2021
1	Non-alcoholic Fatty Liver Disease 07/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2020
1	Infections 01/2019
1	Melanoma (Melanoma, Malignant) 11/2018
1	Drug-Related Side Effects and Adverse Reactions 12/2015
1	Underactive Urinary Bladder 01/2010

7	AntigensIBA 01/2022 - 11/2012
6	Peptides (Polypeptides)IBA 01/2022 - 04/2013
3	EpitopesIBA 01/2020 - 01/2018
2	Protein Subunit VaccinesIBA 01/2022 - 12/2015
2	InterferonsIBA 02/2021 - 11/2018
2	Fetal Proteins (Fetoprotein)IBA 01/2020 - 01/2017
2	Multidrug Resistance-Associated ProteinsIBA 11/2018 - 12/2015
2	squamous cell carcinoma-related antigenIBA 11/2018 - 01/2017
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2018 - 08/2015
1	Biomarkers (Surrogate Marker)IBA 06/2021
1	Therapeutic UsesIBA 06/2021
1	Immune Checkpoint InhibitorsIBA 02/2021
1	NitrogenIBA 02/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	CytokinesIBA 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2018
1	Epithelial Cell Adhesion MoleculeIBA 11/2018
1	EnzymesIBA 11/2018
1	Carcinoembryonic AntigenIBA 11/2018
1	KinesinsIBA 11/2018
1	Mucin 5ACIBA 11/2018
1	GlypicansIBA 11/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017
1	Sorafenib (BAY 43-9006)FDA Link 01/2016
1	ChondroitinIBA 11/2012
1	Glucuronic Acid (Glucuronate)IBA 11/2012
1	distigmine (distigmine bromide)IBA 01/2010
1	Cholinergic Agents (Cholinergics)IBA 01/2010
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2010
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2010